“The goal is to develop life-saving medications for patients faster. That comes down to saving time and money,” said Bonne ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights how artificial intelligence, real-time monitoring, and historical data can aid in optimizing trial design.